A randomized controlled trial of csDMARDs combined with Tripterygium glycoside tablets in the treatment of rheumatoid arthritis
开始日期2024-09-01
申办/合作机构-
NCT02044952
/ Unknown status临床2/3期IIT
Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
The purpose of this study is to assess the effect and safety of Tripterygium Glycosides in the treatment of Crohn's disease for induction remission and compare the therapeutic effect with patients who received mesalazine.